PCOS and Hair Loss in Indian Women
What’s Really Happening and What Actually Works
By Dr. Nav Vikram Kamboj | NeoGraft Hair Clinic, Chandigarh
PCOS (Polycystic Ovary Syndrome) affects approximately 1 in 5 Indian women — making it one of the most common endocrine conditions in India, and one of the most undertreated causes of female hair loss. Among the constellation of PCOS symptoms — irregular periods, weight gain, acne, and fertility challenges — hair thinning is frequently the most psychologically distressing, yet often the least directly addressed by treating physicians.
The Science Behind PCOS-Related Hair Loss
PCOS drives hair loss through hormonal imbalance: elevated androgens (testosterone, DHEA-S) and insulin resistance both contribute to follicular miniaturisation, similar in mechanism to male pattern baldness but typically presenting as diffuse thinning rather than defined recession. The scalp’s frontal and crown zones are most affected. Elevated androgens increase DHT activity in scalp follicles, shortening the growth cycle and progressively miniaturising affected follicles. Insulin resistance compounds this by promoting further androgen production from the ovaries and adrenal glands.
What Most Women Get Wrong About PCOS Hair Loss
“It will resolve when my PCOS improves” — Partially true. Hormonal stabilisation can slow or halt further loss, but follicles that have already miniaturised significantly often require direct treatment to recover. “Biotin and supplements will fix it” — Biotin deficiency is rare, and supplementation helps only if a deficiency exists. Androgen-driven follicular miniaturisation requires anti-androgen or surgical intervention, not nutritional supplementation. “Hair transplant isn’t an option for women” — Female hair transplantation is a well-established procedure. The approach differs from male transplantation (typically addressing diffuse thinning rather than defined recession zones), but is absolutely viable for the right candidates.
Treatment Options: What the Evidence Shows
Hormonal management (first-line): Anti-androgen medications (spironolactone, cyproterone acetate), combined oral contraceptives, metformin for insulin resistance, and lifestyle interventions can reduce androgen activity and slow hair loss progression. Topical treatments: Minoxidil (topical or low-dose oral) is FDA-approved for female pattern hair loss and can be effective alongside hormonal management. GFC/PRP therapy: Growth Factor Concentrate injections support follicle health and can partially reverse early miniaturisation. Surgical restoration: For women with stable PCOS who have experienced significant permanent loss, FUE hair transplantation — including NeoGraft’s NeoDHT® female hair transplant protocol — can restore density in affected zones.
Frequently Asked Questions
Can PCOS cause permanent hair loss?
Yes. If androgen-driven miniaturisation progresses without treatment for an extended period, follicles can become permanently dormant. Early treatment — hormonal and/or topical — is important to preserve as many follicles as possible.
Is hair transplant suitable for women with PCOS?
Female hair transplantation is suitable for PCOS patients who have stable disease (managed hormonal levels), sufficient donor density, and specific zones of significant permanent loss. A clinical assessment with trichoscopy is needed to determine candidacy. NeoGraft offers female-specific hair transplant protocols including NeoDHT®.
Does treating PCOS stop hair loss?
Effective PCOS management (hormonal stabilisation, insulin sensitisation) typically slows or halts further hair loss. It may also partially reverse early-stage miniaturisation. However, follicles that have already undergone significant permanent miniaturisation require direct hair restoration treatment.
Book a Consultation for Female Hair Loss
NeoGraft Chandigarh — Female Hair Restoration Specialists
Book a consultation with Dr. Nav Vikram Kamboj